Search research articles
Contact Us
Filters
Showing results (101-110 of 380) with videos related to
Page
of 38
Sort By:
Cancer
|
February 10, 2018
Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR
Anna Sureda, Mei-Jie Zhang, Peter Dreger, et al.
Experimental Hematology
|
July 24, 2002
CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections
Albert Altès, Jorge Sierra, Jordi Esteve, et al.
Leukemia & Lymphoma
|
November 6, 2019
Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution
María Queralt Salas, Santiago Mercadal, Eva Domingo Domenech, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2004
Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment
Raymond Miralbell, Gemma Sancho, Sabine Bieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis
Rafael F Duarte, Ariane Boumendil, Francesco Onida, et al.
JMIR Formative Research
|
June 4, 2024
Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study
Lidia Hurtado, Melinda Gonzalez Concepcion, Aida Flix-Valle, et al.
The Lancet. Haematology
|
September 29, 2022
Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper
Nico Gagelmann, Anna Sureda, Silvia Montoto, et al.
Bone Marrow Transplantation
|
May 17, 2020
Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT
Anna Sureda, Sonja Genadieva Stavrik, Ariane Boumendil, et al.
Leukemia & Lymphoma
|
July 5, 2013
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant
Simon J Harrison, Andy K Hsu, Paul Neeson, et al.
BMJ Open
|
July 25, 2023
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study
Carlos Solano, Pedro Castro-Rebollo, Antonio Pérez-Martínez, et al.
Page
of 38
Search research articles
Search
Showing results (101-110 of 380) with videos related to
Sort By:
Page
of 38
Cancer
|
February 10, 2018
Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR
Anna Sureda, Mei-Jie Zhang, Peter Dreger, et al.
Experimental Hematology
|
July 24, 2002
CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections
Albert Altès, Jorge Sierra, Jordi Esteve, et al.
Leukemia & Lymphoma
|
November 6, 2019
Validation of the NCCN-IPI and the GELTAMO-IPI for diffuse large B-Cell lymphoma treated with R-CHOP in a large cohort of patients from a single institution
María Queralt Salas, Santiago Mercadal, Eva Domingo Domenech, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 18, 2004
Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment
Raymond Miralbell, Gemma Sancho, Sabine Bieri, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2014
Long-term outcome of allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: a European society for blood and marrow transplantation lymphoma working party extended analysis
Rafael F Duarte, Ariane Boumendil, Francesco Onida, et al.
JMIR Formative Research
|
June 4, 2024
Telemedicine With Wearable Technologies in Patients Undergoing Hematopoietic Cell Transplantation and Chimeric Antigen Receptor T-Cell Therapy (TEL-HEMATO Study): Prospective Noninterventional Single-Center Study
Lidia Hurtado, Melinda Gonzalez Concepcion, Aida Flix-Valle, et al.
The Lancet. Haematology
|
September 29, 2022
Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper
Nico Gagelmann, Anna Sureda, Silvia Montoto, et al.
Bone Marrow Transplantation
|
May 17, 2020
Changes in patients population and characteristics of hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma: an analysis of the Lymphoma Working Party of the EBMT
Anna Sureda, Sonja Genadieva Stavrik, Ariane Boumendil, et al.
Leukemia & Lymphoma
|
July 5, 2013
Early thymus and activation-regulated chemokine (TARC) reduction and response following panobinostat treatment in patients with relapsed/refractory Hodgkin lymphoma following autologous stem cell transplant
Simon J Harrison, Andy K Hsu, Paul Neeson, et al.
BMJ Open
|
July 25, 2023
Quantifying the available capacity and resource needs for provision of CAR-T therapies in the National Health Service in Spain: a survey-based study
Carlos Solano, Pedro Castro-Rebollo, Antonio Pérez-Martínez, et al.
Page
of 38